small cell lung cancer
Conditions
Interventions
A:Naught
B:Live Bacillus licheniformis capsule
C:Live Combined Bacillus Subtilis and Enterocoocus Faecium Enteric-coated Capsules
D:Triple Viable Capsules Dissolving at Intestines
Sponsors
The Second Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Voluntarily participated in this study, fully understood, informed about this study and signed an informed consent form. 2.Patients with histologically confirmed primary small-cell lung cancer. 3.The age of the patients was 18-80 years old (including). ECOG score was 0-1. 4.Assessable lesions on CT or MRI and at least one assessment was available. 5.The patients agreed to abstain from smoking and drinking, and to refrain from spicy and irritating foods during the study.
Exclusion criteria
Exclusion criteria: 1.Patients with autoimmune diseases or digestive system diseases. 2.Patients with secondary primary malignancies. 3.Patients who took antibiotics, laxatives, immunosuppressants, microecological agents, etc. within 1 month. 4.Patients with infectious diseases such as viral hepatitis, HIV, syphilis, etc. 5.Patients requiring recent high-dose hormone therapy, active brain metastases requiring treatment, and leptomeningeal metastases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease control rate;Objective Response Rate;Quality of life;Progression-free survival; | — |
Countries
China
Contacts
Public ContactChen Jun
The Second Hospital of Dalian Medical University
Outcome results
None listed